Business Wire

NetApp Powers Porsche Motorsport to ABB FIA Formula E World Championship Wins with Data-driven Cloud Solutions

13.7.2022 15:00:00 EEST | Business Wire | Press release

Share

NetApp® (NASDAQ: NTAP), a global cloud-led, data-centric software company, and TAG Heuer Porsche Formula E Team, today announced a multi-year partnership. NetApp will provide the sportscar maker with innovative hybrid cloud solutions that will help them continue to write car racing history.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220713005218/en/

Porsche AG, a global automotive brand owned by Volkswagen Group, has begun shifting production towards electric or e-fuel powered vehicles in 2015. By the year 2030, Porsche AG aims for 80% of all vehicles sold to be electric. Tapping into NetApp’s real-time data services, TAG Heuer Porsche Formula E Team helps deliver on the vision of sustainable mobility while enabling the real-time adjustments that deliver superior race performance – and help drive the next generation of Porsche electric vehicles.

Real-time data collaboration service for the racetrack

NetApp's hybrid cloud solutions enable TAG Heuer Porsche Formula E Team to access their data trackside to support driver and team performance. This helps them make data-driven decisions in real-time, for example when to use the Formula E Attack Mode, which unlocks an additional 30 kilowatts of engine power. The rules about engaging Attack Mode are set by FIA shortly before every ePrix, hence it has a great impact on race strategy.

With data at the core of racing, business, and engineering decisions, the TAG Heuer Porsche Formula E Team requires cutting-edge data management technology:

  • Data and systems need to be available at the racetrack and fulfill demanding performance requirements.
  • Digital data collected during the ePrix must be uploaded to the cloud for analysis while the race is still running.
  • Cloud data needs to be processed by the team at Porsche Motorsport headquarters in Weissach, Germany for R&D.
  • After the race, data must be transferred to the cloud so it can be utilized in the future, and to support crucial data services such as backup and archiving.

The hybrid cloud data solution designed by NetApp and Porsche in response combines cloud network-attached (NAS) storage services with Global File Cache to ensure data can flow seamlessly and quickly between different widely dispersed locations. It also integrates powerful NetApp data services to ensure version consistency, manage and monitor cloud resources, and protect Porsche’s intellectual property:

  • Cloud Volumes ONTAP is the primary storage platform for TAG Heuer Porsche Formula E Team. The multicloud solution deployed on Azure acts as a hub that consolidates all the team’s data.
  • Global File Cache, the cloud volume edge capability provides local edge instances, enabling low-latency access to a common dataset, both at the on-premises development center in Weissach and the racetrack.
  • Cloud Manager delivers centralized orchestration across hybrid cloud storage infrastructure and all data management services, so that TAG Heuer Porsche Formula E Team can manage, monitor and automate all their data software and hardware consumption.
  • Cloud Backup integrates as backup and archive layer for the consolidated cloud data.

“Formula E is a technology showcase and R&D backbone for Porsche and preserves our strong motorsports heritage on the road and on the track,” said Friedemann Kurz, Head of Motorsport IT, Porsche. “Data is the defining element here, but it is not easy to harness when the racing team is always on the road. The solution created by NetApp is unique in the market in how it can move huge amounts of data at high speed while delivering an intuitive experience across edge, core and cloud so we can design better, faster cars for our racecar drivers and car enthusiasts everywhere.”

“This is a winning partnership in which two champions meet eye-to-eye. Porsche has secured over 30,000 wins in all major car racing series. NetApp has submitted more than 2,500 data innovation patents. Joining forces now, we are working to make our mark on the future of racing,” said James Whitemore, Executive Vice President and Chief Marketing Officer at NetApp. “Digital data is collected by the cars’ many sensors as they dart along the track and is processed synchronously to predict outcomes to aid the trackside team. Data equals speed.”

Additional Resources

About NetApp

NetApp is a global, cloud-led, data-centric software company that empowers organizations to lead with data in the age of accelerated digital transformation. The company provides systems, software and cloud services that enable them to run their applications optimally from data center to cloud, whether they are developing in the cloud, moving to the cloud, or creating their own cloudlike experiences on premises. With solutions that perform across diverse environments, NetApp helps organizations build their own data fabric and securely deliver the right data, services and applications to the right people—anytime, anywhere. Learn more at www.netapp.com or follow us on Twitter, LinkedIn, Facebook, and Instagram.

NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc.

About Porsche in Formula E

With the Porsche 99X Electric, Porsche returned to open-wheel single-seater racing in 2019 after more than 30 years and celebrated a successful debut scoring second place at the season-opener in Saudi Arabia’s Diriyah in the ABB Formula E season 6. In 2021/2022, the TAG Heuer Porsche Formula E Team contests its third Formula E season with the Porsche 99X Electric – and clinched an historic one-two result in Mexico on 12 February 2022. The fully electric racing car sporting the Weissach-developed Porsche E Performance Powertrain also serves as a development platform for the sports car manufacturer’s fully electric production models. Energy management and efficiency are important factors of success in Formula E and in the development of production cars. For the 2021/2022 season, the 99X Electric has a maximum output of 250 kW in qualification mode and 220 kW (last season 200 kW) in normal race mode. Attack Mode boosts the output to 250 kW (last season 235 kW). Maximum recuperation is 250 kW; the usable battery capacity is 52 Kilowatt-hours.

Formula E is the Fédération Internationale de l'Automobile’s (FIA) innovative and sustainable international championship for electric open-wheel racing cars.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media Contacts:
Kenya Hayes
NetApp
kenya.hayes@netapp.com

Marvin Sauer
NetApp
marvin.sauer@netapp.com

Viktoria Wohlrapp
Porsche
viktoria.wohlrapp@porsche.de

Investor Contact:
Lance Berger
NetApp
lance.berger@netapp.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

U.S. FDA Grants Priority Review to BeOne Medicines’ BRUKINSA Combination in First-Line Mantle Cell Lymphoma4.11.2026 16:13:00 EET | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to the supplemental New Drug Application (sNDA) for BRUKINSA® (zanubrutinib) in combination with rituximab for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL). The application is supported by data from the pivotal Phase 3 MANGROVE study, in which this chemotherapy-free regimen significantly reduced the risk of disease progression or death compared with standard chemoimmunotherapy. Full results from the MANGROVE study will be presented during the Plenary Scientific Session at the 68th American Society of Hematology (ASH) Annual Meeting on December 13, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261103605806/en/ BeOne Medicines' flagship U.S. manufacturing and clinical R&D facility at the P

Incyte to Present New Data Highlighting Progress Across its Hematology Portfolio at ASH 20264.11.2026 16:00:00 EET | Press release

Incyte (Nasdaq:INCY) today announced that new data highlighting progress across its hematology portfolio will be presented across more than 30 abstracts at the 2026 American Society of Hematology (ASH) Annual Meeting, to beheld December 12 – 15, 2026, in New Orleans. “Our ASH presentations demonstrate meaningful progress across our Hematology portfolio to advance novel treatment approaches for people with serious hematologic conditions,” said Pablo J. Cagnoni, M.D., President, Incyte and Global Head of Research and Development. "We are particularly encouraged by the continued clinical progress of INCA033989 in myelofibrosis (MF) and essential thrombocythemia (ET) and the data for latarcibart in von Willebrand disease (VWD) - data that support our goal of advancing differentiated medicines with the potential to meaningfully improve outcomes for patients." Details on key data presentations at ASH include: Oral Presentations INCA033989 (mutCALR) In JAK-Inhibitor Naive Patients with Myelof

Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement4.11.2026 16:00:00 EET | Press release

Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™ and the leading third-party support provider for Oracle, SAP and VMware software, today announced that it had been selected as the awardee of the third-party support service lots (TMA) by CANUT, the French public purchasing center specializing in digital technology and telecommunications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104431817/en/ Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement Eligible public organizations subject to the French Public Procurement Code can now benefit from Rimini Street services for their Oracle, SAP, VMware and IBM environments, without having to go through a lengthy individual tender process. Through Rimini Support™, organizations gain access to a support alternative enabling them to significantly reduce their historical support costs, improve service quality and support respons

Zenitar Announces Initiation of International Randomized Study of Flonoltinib Maleate in Patients with Myelofibrosis and Related American Society of Hematology 2026 Meeting Presentations4.11.2026 16:00:00 EET | Press release

Chengdu Zenitar Biomedical Technology Co., Ltd. (Zenitar) is developing flonoltinib maleate (FM), a first-in-class oral JAK2/FLT3/CDK6 inhibitor for myeloproliferative neoplasms (MPNs), including myelofibrosis (MF) and polycythemia vera (PV). Zenitar launched randomized Phase 2 FM-MF-02 (NCT07750574) in the US, Canada and Brazil to select Phase 3 dose for JAKi-naïve and refractory MF. Randomized FMF-02 (NCT06457425) met its week-24 endpoints: superior SVR35 and TSS50 with FM 50/100mg versus ruxolitinib; previous data presented orally at ASH24 (#486) and ASH25 (#908). ASH 2026 presence covers FMF-02 long-term follow-up (oral presentation, #411, December 12, 4:30pm) and refractory PV Phase 2 data (poster, #3765, December 13, 6pm), both in Session 634. “Over the 15 years since the initial FDA approval of Ruxolitinib, JAKi have markedly improved the prognosis of many patients with MF. The long-term data show significant room for improvement for this key therapeutic class in terms of both e

Trained Therapeutix Discovery Appoints Andrew Glass as Chief Executive Officer4.11.2026 15:41:00 EET | Press release

Trained Therapeutix Discovery ("TTxD"), a pioneering immunotherapy company founded by the Jean Boulle Group and the Heritage Group, which is developing nanomedicines to regulate innate immunity, announces the appointment of Andrew Glass as Chief Executive Officer with immediate effect. Mr. Glass has more than 20 years of leadership experience in the life sciences industry as Chief Executive Officer of Vivasure Medical and previously from over 15 years in senior leadership roles at Abbott. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104178009/en/ Andrew Glass, CEO, TTxD Following the previously announced changes to the Company’s Board earlier this year, Mr. Glass joins the Company as it transitions from preclinical stage to being a clinical-stage organisation. His expertise in developmental strategy, financing and organisational growth is focussed on expediting the delivery of the aims associated with TTxD’s proprietary

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye